Sexual dysfunction during perimenopause among women prescribed hormone replacement therapy may have more to do with psychosocial factors, not menopausal symptoms.
The objective of this study was to investigate the associations between endogenous FSH levels and BMD, BMA, and body composition in older adults, independent of estradiol and testosterone levels.
The aim of this study was to evaluate the possible effects of radioactive iodine therapy on ovarian function and fertility in women.
Scientific statement by AHA detailing the current understanding of menopause transition and its impact on the risk for postmenopausal cardiovascular disease.
Having two or more moderate or severe menopausal symptoms (MS) is associated with an increased risk for stroke and cardiovascular disease.
Perimenopausal women with a history of hypertensive disorders may be candidates for anticipatory guidance for menopause symptom management.
Among women with menopausal vasomotor symptoms, severity rather than frequency of hot flushes and night sweats is associated with an increased risk for CVD.
For postmenopausal women, antidepressants, beta-blockers, and insulin are associated with weight gain over three years.
Serum allopregnanolone levels are lower in women with either menstrually related or postmenopausal migraine compared with women without headache.
Lifestyle factors and health status affect the incidence of depression in postmenopausal women, according to cross-sectional study results.
In recently menopausal women using hormone treatment, circulating levels of pituitary-ovarian hormones are associated with changes in white matter hyperintensities.